114 related articles for article (PubMed ID: 12794567)
1. Delayed-type hypersensitivity skin testing can predict CD4 count increase in HIV patients with poor immunologic response to HAART.
Meroni L; Marchetti G; Gatti N; Monforte Ad; Galli M
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):277-8. PubMed ID: 12794567
[No Abstract] [Full Text] [Related]
2. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia.
Wendland T; Furrer H; Vernazza PL; Frutig K; Christen A; Matter L; Malinverni R; Pichler WJ
AIDS; 1999 Oct; 13(14):1857-62. PubMed ID: 10513643
[TBL] [Abstract][Full Text] [Related]
3. Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.
López de Castilla D; Verdonck K; Otero L; Iglesias D; Echevarría J; Lut L; Gotuzzo E; Seas C
Int J Infect Dis; 2008 May; 12(3):325-31. PubMed ID: 18546542
[TBL] [Abstract][Full Text] [Related]
4. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
5. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
6. CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
Okulicz JF; Grandits GA; Weintrob AC; Landrum ML; Ganesan A; Crum-Cianflone NF; Agan BK; Marconi VC
Clin Infect Dis; 2010 Apr; 50(8):1187-91. PubMed ID: 20218878
[TBL] [Abstract][Full Text] [Related]
7. Polyactin A can increase CD4+T cell counts in HIV-infected individuals with insufficient immunologic response to HAART: is it a reality?
Li Q; Zhang L; Yang J; Liu Z
Int J STD AIDS; 2014 Nov; 25(13):975. PubMed ID: 25318857
[No Abstract] [Full Text] [Related]
8. HIV DNA and immune alteration during successful HAART.
Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
[TBL] [Abstract][Full Text] [Related]
9. Autologous CCR5-modified CD4 T-cells effective in HAART nonresponders.
AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22132424
[No Abstract] [Full Text] [Related]
10. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
11. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
Al-Harthi L; Voris J; Patterson BK; Becker S; Eron J; Smith KY; D'Amico R; Mildvan D; Snidow J; Pobiner B; Yau L; Landay A
HIV Med; 2004 Jan; 5(1):55-65. PubMed ID: 14731171
[TBL] [Abstract][Full Text] [Related]
13. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
[TBL] [Abstract][Full Text] [Related]
14. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
[No Abstract] [Full Text] [Related]
15. The prognosis of patients with dissociated virological and immunological responses to HAART.
Jevtović D; Salemović D; Ranin J; Pešić-Pavlović I; Korać M; Djurković-Djaković O
Biomed Pharmacother; 2010 Dec; 64(10):692-6. PubMed ID: 20863649
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
17. Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy.
van Leth F; Wit FW; Reiss P; Schattenkerk JK; van der Ende ME; Schneider MM; Mulder JW; Frissen PH; de Wolf F; Lange JM
HIV Med; 2004 Mar; 5(2):74-81. PubMed ID: 15012645
[TBL] [Abstract][Full Text] [Related]
18. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K
HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993
[TBL] [Abstract][Full Text] [Related]
19. Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.
Kousignian I; Abgrall S; Duval X; Descamps D; Matheron S; Costagliola D;
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):50-7. PubMed ID: 14501793
[TBL] [Abstract][Full Text] [Related]
20. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
